Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call

GlobeNewswire October 10, 2018

NeuroMetrix Reports Publication of New Clinical Study on Quell Wearable Pain Relief Technology

GlobeNewswire October 2, 2018

NeuroMetrix To Present Quell 2.0 at DTxDM East: The Digital Therapeutics and Digital Medicine Event in Boston

GlobeNewswire September 25, 2018

NeuroMetrix Reports Discussion of Quell Wearable Pain Relief Technology on the Fox Business Network

GlobeNewswire September 20, 2018

NeuroMetrix To Introduce Quell 2.0: The Next Generation, Wearable Pain Relief Technology at PAINWeek 2018

PR Newswire September 4, 2018

NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB

GlobeNewswire August 29, 2018

NeuroMetrix Reports Presentation of Clinical and Scientific Data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference

GlobeNewswire August 28, 2018

NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City

GlobeNewswire August 27, 2018

NeuroMetrix Announces Participation at the 20th Annual Global Investment Conference in New York City September 4 - 6th, 2018

GlobeNewswire August 23, 2018

NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare

GlobeNewswire August 21, 2018

NeuroMetrix Reports Q2 2018 Financial Results

GlobeNewswire July 19, 2018

NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call

GlobeNewswire July 12, 2018

NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology

GlobeNewswire July 5, 2018

NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards

GlobeNewswire June 28, 2018

NeuroMetrix Reports Publication of New Clinical Studies on DPNCheck

GlobeNewswire June 26, 2018

NeuroMetrix Report Highlights Stigma Faced by Chronic Pain Community around Opioid Use, Desire for Alternative Treatments

GlobeNewswire June 21, 2018

NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare

GlobeNewswire June 19, 2018

Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress

GlobeNewswire May 3, 2018

NeuroMetrix, Inc. to Participate in Upcoming Disruptive Growth & Healthcare Conference in New York City

GlobeNewswire May 1, 2018

NeuroMetrix Reports Q1 2018 Financial Results

GlobeNewswire April 19, 2018